Stockreport

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 [Yahoo! Finance]

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF – Linaclotide data presentations highlight efficacy and safety insights in IBS-C, CIC and pediatric FC – BOSTON, April 23, 2026 BUSINESS WIRE Ironwood Pharmaceuticals [Read more]